Recursion Pharmaceuticals (RXRX) Selling, General & Administrative (2020 - 2026)

Recursion Pharmaceuticals (RXRX) Selling, General & Administrative (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Recursion Pharmaceuticals 1.69 Bn 1.14 Bn -3.82 Mn 41.53 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 41.53 Mn
Mar 31, 2026 34.59 Mn
Dec 31, 2025 33.66 Mn
Sep 30, 2025 41.63 Mn
Jun 30, 2025 46.65 Mn
Mar 31, 2025 54.65 Mn
Dec 31, 2024 77.19 Mn
Sep 30, 2024 37.76 Mn
Jun 30, 2024 31.83 Mn
Mar 31, 2024 31.41 Mn
Dec 31, 2023 30.46 Mn
Sep 30, 2023 29.20 Mn
Jun 30, 2023 28.29 Mn
Mar 31, 2023 22.87 Mn
Dec 31, 2022 19.84 Mn
Sep 30, 2022 19.49 Mn
Jun 30, 2022 21.20 Mn
Mar 31, 2022 21.07 Mn
Dec 31, 2021 19.20 Mn
Sep 30, 2021 15.69 Mn